Ascension St. John Clinical Research Institute

Tulsa, Oklahoma 76104

2 studies enrolling now · 9 studies all time

What they study most

ASCVD, Acute Ischemic Stroke, COVID-19, Coronavirus Disease 2019, Covid19, Disease Caused by Severe Acute Respiratory Syndrome Coronavirus 2, Hemorrhage, Invasive Procedure, Obstructive Hypertrophic Cardiomyopathy (oHCM), Peripheral Vascular Diseases, Symptomatic Hypertrophic Cardiomyopathy (HCM), Urgent Surgery

Studies at this site

• Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral Vasculature — Recruiting now
• A Phase 2b, Randomized, Double-blind Study of Redasemtide (S-005151) in Adult Participants With Acute Ischemic Stroke — Completed
• Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic oHCM — Completed
• Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Aficamten in Adults With HCM — Enrolling by invitation
• Study of Varespladib in Patients Hospitalized With Severe COVID-19 — Stopped early
• Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 ACUTE — Completed
• Bentracimab in Ticagrelor-treated Patients With Uncontrolled Bleeding or Requiring Urgent Surgery or Invasive Procedure — Completed
• COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80 — Stopped early
• The Cardiovascular Multi-dimensional Observational Investigation of the Use of PCSK9 Inhibitors (cvMOBIUS) — Stopped early